Summary
Altria Group, Inc. has officially been released from its non-competition obligations related to its investment in JUUL Labs, Inc., effective September 29, 2022. This release was triggered by the substantial decline in the carrying value of Altria's JUUL investment, which has fallen below the 10% threshold of its initial $12.8 billion value. As of June 30, 2022, the carrying value was $450 million. This development allows Altria to re-enter the e-vapor business independently, a significant strategic shift. However, this release comes at the cost of several rights associated with its JUUL investment, including board designation rights (except for one independent director appointment as long as ownership remains at least 10%), preemptive rights, consent rights, and other related privileges. The conversion of Altria's JUUL shares to single-vote common stock also drastically reduces its voting power within JUUL.
Key Highlights
- 1Altria is no longer bound by non-competition obligations to JUUL.
- 2The release was exercised due to the JUUL investment's carrying value falling below 10% of its initial $12.8 billion value.
- 3As of June 30, 2022, the JUUL investment's carrying value was $450 million.
- 4Altria can now independently participate in the e-vapor market.
- 5Altria loses JUUL board designation rights (except for one director if ownership remains above 10%).
- 6Preemptive rights, consent rights, and certain other investment-related rights with JUUL have been terminated.
- 7Altria's voting power in JUUL is significantly reduced due to share conversion to single-vote common stock.